Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001558370-24-011511
Filing Date
2024-08-08
Accepted
2024-08-08 11:14:11
Documents
69
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 6-K gmab-20240630x6k.htm 6-K 22446
2 EX-99.1 gmab-20240630xex99d1.htm   iXBRL EX-99.1 1759414
3 GRAPHIC gmab-20240630xex99d1002.jpg GRAPHIC 4880
4 GRAPHIC gmab-20240630xex99d1005.jpg GRAPHIC 100206
5 GRAPHIC gmab-20240630xex99d1006.jpg GRAPHIC 81897
6 GRAPHIC gmab-20240630xex99d1007.jpg GRAPHIC 1353
7 GRAPHIC gmab-20240630xex99d1009.jpg GRAPHIC 2455
8 GRAPHIC gmab-20240630xex99d1010.jpg GRAPHIC 4097
9 GRAPHIC gmab-20240630xex99d1011.jpg GRAPHIC 1757
10 GRAPHIC gmab-20240630xex99d1012.jpg GRAPHIC 2062
11 GRAPHIC gmab-20240630xex99d1013.jpg GRAPHIC 2922
12 GRAPHIC gmab-20240630xex99d1014.jpg GRAPHIC 3226
13 GRAPHIC gmab-20240630xex99d1015.jpg GRAPHIC 2771
14 GRAPHIC gmab-20240630xex99d1016.jpg GRAPHIC 4948
15 GRAPHIC gmab-20240630xex99d1017.jpg GRAPHIC 2240
16 GRAPHIC gmab-20240630xex99d1018.jpg GRAPHIC 3213
17 GRAPHIC gmab-20240630xex99d1019.jpg GRAPHIC 1092
  Complete submission text file 0001558370-24-011511.txt   6241301

Data Files

Seq Description Document Type Size
18 EX-101.SCH gmab-20240630.xsd EX-101.SCH 48060
19 EX-101.CAL gmab-20240630_cal.xml EX-101.CAL 56625
20 EX-101.DEF gmab-20240630_def.xml EX-101.DEF 144592
21 EX-101.LAB gmab-20240630_lab.xml EX-101.LAB 339795
22 EX-101.PRE gmab-20240630_pre.xml EX-101.PRE 232387
72 EXTRACTED XBRL INSTANCE DOCUMENT gmab-20240630xex99d1_htm.xml XML 1017872
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Filer) CIK: 0001434265 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38976 | Film No.: 241186817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)